Evans Electric Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 13, 2025, 11:58 pm

Competitors of Evans Electric Ltd

All Competitor Stocks of Evans Electric Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:06 am

Below is a detailed analysis of the quarterly data for Evans Electric Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 20.71 Cr.. The value appears strong and on an upward trend. It has increased from 4.77 Cr. (Sep 2024) to 20.71 Cr., marking an increase of 15.94 Cr..
• For Expenses, as of Mar 2025, the value is 12.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.46 Cr. (Sep 2024) to 12.46 Cr., marking an increase of 9.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 8.25 Cr.. The value appears strong and on an upward trend. It has increased from 1.31 Cr. (Sep 2024) to 8.25 Cr., marking an increase of 6.94 Cr..
• For OPM %, as of Mar 2025, the value is 39.84%. The value appears strong and on an upward trend. It has increased from 27.46% (Sep 2024) to 39.84%, marking an increase of 12.38%.
• For Other Income, as of Mar 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Sep 2024) to 0.79 Cr., marking an increase of 0.54 Cr..
• For Interest, as of Mar 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.14 Cr. (Sep 2024) to 0.19 Cr., marking an increase of 0.05 Cr..
• For Depreciation, as of Mar 2025, the value is 0.12 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.11 Cr. (Sep 2024) to 0.12 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Mar 2025, the value is 8.73 Cr.. The value appears strong and on an upward trend. It has increased from 1.31 Cr. (Sep 2024) to 8.73 Cr., marking an increase of 7.42 Cr..
• For Tax %, as of Mar 2025, the value is 24.51%. The value appears to be improving (decreasing) as expected. It has decreased from 25.19% (Sep 2024) to 24.51%, marking a decrease of 0.68%.
• For Net Profit, as of Mar 2025, the value is 6.59 Cr.. The value appears strong and on an upward trend. It has increased from 0.98 Cr. (Sep 2024) to 6.59 Cr., marking an increase of 5.61 Cr..
• For EPS in Rs, as of Mar 2025, the value is 12.01. The value appears strong and on an upward trend. It has increased from 1.78 (Sep 2024) to 12.01, marking an increase of 10.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:23 am

Growth

Last Updated: September 5, 2025, 3:26 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Evans Electric Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 21.90. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 21.90, marking an increase of 3.42.
• For Diluted EPS (Rs.), as of Mar 25, the value is 21.90. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 21.90, marking an increase of 3.42.
• For Cash EPS (Rs.), as of Mar 25, the value is 14.24. This value is within the healthy range. It has decreased from 19.34 (Mar 24) to 14.24, marking a decrease of 5.10.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 47.88. It has decreased from 71.08 (Mar 24) to 47.88, marking a decrease of 23.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 47.88. It has decreased from 71.08 (Mar 24) to 47.88, marking a decrease of 23.20.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. It has decreased from 3.00 (Mar 24) to 1.50, marking a decrease of 1.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.46. It has decreased from 75.33 (Mar 24) to 46.46, marking a decrease of 28.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 19.33. This value is within the healthy range. It has decreased from 25.13 (Mar 24) to 19.33, marking a decrease of 5.80.
• For PBIT / Share (Rs.), as of Mar 25, the value is 18.91. This value is within the healthy range. It has decreased from 24.26 (Mar 24) to 18.91, marking a decrease of 5.35.
• For PBT / Share (Rs.), as of Mar 25, the value is 18.31. This value is within the healthy range. It has decreased from 23.34 (Mar 24) to 18.31, marking a decrease of 5.03.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 13.81. This value is within the healthy range. It has decreased from 18.48 (Mar 24) to 13.81, marking a decrease of 4.67.
• For PBDIT Margin (%), as of Mar 25, the value is 41.61. This value is within the healthy range. It has increased from 33.35 (Mar 24) to 41.61, marking an increase of 8.26.
• For PBIT Margin (%), as of Mar 25, the value is 40.69. This value exceeds the healthy maximum of 20. It has increased from 32.21 (Mar 24) to 40.69, marking an increase of 8.48.
• For PBT Margin (%), as of Mar 25, the value is 39.40. This value is within the healthy range. It has increased from 30.98 (Mar 24) to 39.40, marking an increase of 8.42.
• For Net Profit Margin (%), as of Mar 25, the value is 29.72. This value exceeds the healthy maximum of 10. It has increased from 24.53 (Mar 24) to 29.72, marking an increase of 5.19.
• For Return on Networth / Equity (%), as of Mar 25, the value is 28.84. This value is within the healthy range. It has increased from 26.00 (Mar 24) to 28.84, marking an increase of 2.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 39.33. This value is within the healthy range. It has increased from 34.01 (Mar 24) to 39.33, marking an increase of 5.32.
• For Return On Assets (%), as of Mar 25, the value is 21.65. This value is within the healthy range. It has increased from 20.54 (Mar 24) to 21.65, marking an increase of 1.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 0.99 (Mar 24) to 0.85, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 25, the value is 2.18. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 2.18, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 2.09. This value exceeds the healthy maximum of 2. It has increased from 2.03 (Mar 24) to 2.09, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 37.02. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 37.02, marking an increase of 32.41.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.82 (Mar 24) to 0.00, marking a decrease of 10.82.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.33 (Mar 24) to 0.00, marking a decrease of 10.33.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.18 (Mar 24) to 0.00, marking a decrease of 89.18.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.67 (Mar 24) to 0.00, marking a decrease of 89.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 32.15. This value is within the healthy range. It has increased from 27.29 (Mar 24) to 32.15, marking an increase of 4.86.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.97. This value is within the healthy range. It has increased from 21.07 (Mar 24) to 23.97, marking an increase of 2.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 72.08. It has increased from 56.36 (Mar 24) to 72.08, marking an increase of 15.72.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.83. This value is within the healthy range. It has increased from 2.73 (Mar 24) to 2.83, marking an increase of 0.10.
• For EV / EBITDA (X), as of Mar 25, the value is 6.80. This value is within the healthy range. It has decreased from 8.18 (Mar 24) to 6.80, marking a decrease of 1.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 2.83 (Mar 24) to 2.85, marking an increase of 0.02.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 89.17 (Mar 24) to 0.00, marking a decrease of 89.17.
• For Price / BV (X), as of Mar 25, the value is 2.76. This value is within the healthy range. It has decreased from 3.00 (Mar 24) to 2.76, marking a decrease of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.85. This value is within the healthy range. It has increased from 2.83 (Mar 24) to 2.85, marking an increase of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.10, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness